Filing Details
- Accession Number:
- 0001127602-25-004776
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-02-13 21:02:03
- Reporting Period:
- 2025-02-11
- Filing Date:
- 2025-02-13
- Accepted Time:
- 2025-02-13 21:02:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 318154 | Amgen Inc | AMGN | Biological Products, (No Disgnostic Substances) (2836) | 953540776 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1642156 | Murdo Gordon | One Amgen Center Drive Thousand Oaks CA 91320 | Evp, Global Commercial Ops | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-02-11 | 8,771 | $294.79 | 44,186 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The price reported is an average price. The prices ranged from $294.6101 to $294.885 per share. Full information regarding the number of shares purchased at each separate price within the range set forth is available upon request by the SEC staff, the issuer or a security holder of the issuer.
- These shares include 773 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
Billionaire Hedge Funds
